Description
Trulicity (Dulaglutide)
Trulicity (Dulaglutide) is a medicine used in adults and children from 10 years of age with type 2 diabetes. It is used in addition to appropriate diet and exercise. Trulicity drug is also used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. Trulicity can only be obtained with a prescription. It is available as prefilled pens containing a solution to be injected under the skin in the abdomen.
The active substance in Trulicity, dulaglutide, is a ‘GLP-1 receptor agonist’. It acts in the same way as GLP-1 (a hormone produced in the gut) by increasing the amount of insulin that the pancreas releases in response to food. This helps to control blood glucose levels and symptoms of type 2 diabetes. Trulicity Dulaglutide is given through an injection (needle). You take it once a week by injecting it under the skin of your stomach, thigh, or upper arm. It is not known if Trulicity can be used in people who have had inflammation of the pancreas (pancreatitis).
Trulicity is not for use in people with type 1 diabetes and is not recommended for use in people with severe stomach or intestinal problems. Trulicity was more effective than metformin at reducing HbA1c levels when used alone. About 51% of those given the lower dose and 60% of patients given the higher dose of Trulicity achieved a target HbA1c below 7.0% and this was generally more than the proportion achieving this target with alternative treatments. Trulicity Dulaglutide drug may cause tumors in the thyroid, including thyroid cancer. If you have any of these symptoms, tell your healthcare provider.
